Recurrent B-Cell Non-Hodgkin Lymphoma

Known as: B-Cell Lymphoma Recurrent, Recurrent B-Cell Lymphoma, Recurrent B-Cell Non-Hodgkin's Lymphoma 
The reemergence of B-cell non-Hodgkin lymphoma after a period of remission.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2010
012319892010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Certain malignant B cells rely on B-cell receptor (BCR)-mediated survival signals. Spleen tyrosine kinase (Syk) initiates and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE To evaluate the safety, maximum-tolerated dose (MTD), pharmacokinetics, and antitumor activity of dacetuzumab in patients… (More)
Is this relevant?
2008
2008
Oblimersen sodium plus rituximab was evaluated in relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) patients. Oblimersen was… (More)
Is this relevant?
2008
2008
PURPOSE To report a case of a pseudo-hypopyon as the presentation for recurrent B-cell lymphoma. DESIGN Case report. METHODS… (More)
Is this relevant?
2004
2004
6572 Background: Oblimersen sodium (Genasense;GNS), a phosphorothioate 18-mer antisense oligonucleotide directed against the… (More)
Is this relevant?
2003
2003
Intravascular lymphomatosis (IVL) is a rare type of lymphoma with a poor prognosis. Its distinctive clinical and histopathologic… (More)
Is this relevant?
2000
2000
We present two male siblings suffering from recurrent manifestations of B-cell non-Hodgkin's lymphoma (NHL) and recurrent… (More)
Is this relevant?
1999
1999
Fas-ligand (FasL) is a member of the tumor necrosis factor family and transmits apoptotic cell death signal by binding to its… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
A Phase I/II dose escalation study of 90Y-murine anti-CD20 monoclonal antibody (mAb) in patients with recurrent B-cell lymphoma… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The B-cell antigen CD20 is expressed on normal B cells and by nearly all B-cell lymphomas. This nonmodulating antigen provides an… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?